Gideon R. Hajer

Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome

Gideon R. Hajer, Yolanda van der Graaf, Jobien K. Olijhoek et al. · Heart · 2005 · 88 citations · Full text

Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy

Peter E. Westerweel, Frank L.J. Visseren, Gideon R. Hajer et al. · European Heart Journal · 2008 · 77 citations · Full text

The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients

Gideon R. Hajer, Geesje M. Dallinga‐Thie, Leonie C. van Vark – van der Zee et al. · Atherosclerosis · 2008 · 46 citations

Obesity, Metabolic Syndrome, Metabolic Disorder +8

The Effects of Low-Dose Simvastatin and Ezetimibe Compared to High-Dose Simvastatin Alone on Post-Fat Load Endothelial Function in Patients With Metabolic Syndrome: A Randomized Double-Blind Crossover Trial

Jobien K. Olijhoek, Gideon R. Hajer, Yolanda van der Graaf et al. · Journal of Cardiovascular Pharmacology · 2008 · 44 citations

Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease

Gideon R. Hajer, Yolanda van der Graaf, Jobien K. Olijhoek et al. · American Heart Journal · 2007 · 36 citations

Metabolic Syndrome, Vascular Disease, Cardiovascular Epidemiology +13